IHAM
Integral Health Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.3M | Buy |
+50,000
| New | +$26.3M | 2.4% | 10 |
|
|
2024
Q2 | – | Sell |
-17,000
| Closed | -$16.4M | – | 92 |
|
|
2024
Q1 | $16.4M | Sell |
17,000
-8,000
| -32% | -$7.7M | 1.52% | 22 |
|
|
2023
Q4 | $22M | Buy |
+25,000
| New | +$22M | 2.99% | 5 |
|
|
2023
Q2 | – | Sell |
-3,000
| Closed | -$2.47M | – | 93 |
|
|
2023
Q1 | $2.47M | Buy |
+3,000
| New | +$2.47M | 0.5% | 56 |
|
|
2021
Q4 | – | Sell |
-10,000
| Closed | -$6.05M | – | 82 |
|
|
2021
Q3 | $6.05M | Sell |
10,000
-8,500
| -46% | -$5.14M | 1.74% | 20 |
|
|
2021
Q2 | $10.3M | Buy |
+18,500
| New | +$10.3M | 2.84% | 7 |
|
|
2020
Q3 | – | Sell |
-12,000
| Closed | -$7.48M | – | 83 |
|
|
2020
Q2 | $7.48M | Buy |
+12,000
| New | +$7.48M | 2.24% | 18 |
|